Sonnet BioTherapeutics Files 8-K

Sonnet Biotherapeutics Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanySonnet Biotherapeutics Holdings, Inc.
Form Type8-K
Filed DateMar 26, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, company-update

TL;DR

Sonnet BioTherapeutics filed an 8-K on 3/26/25. Nothing major, just an update.

AI Summary

Sonnet BioTherapeutics Holdings, Inc. filed an 8-K on March 26, 2025, reporting other events. The company, formerly known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC, is incorporated in Delaware and headquartered in Princeton, NJ.

Why It Matters

This filing indicates a routine update or event disclosure for Sonnet BioTherapeutics Holdings, Inc., providing transparency to investors about company activities.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not appear to contain material adverse information.

Key Players & Entities

  • Sonnet BioTherapeutics Holdings, Inc. (company) — Registrant
  • March 26, 2025 (date) — Date of Report
  • Chanticleer Holdings, Inc. (company) — Former Company Name
  • TULVINE SYSTEMS INC (company) — Former Company Name
  • Delaware (jurisdiction) — State of Incorporation
  • Princeton, New Jersey (location) — Principal Executive Offices
  • 08540 (zip_code) — Principal Executive Offices Zip Code
  • (609) 375-2227 (phone_number) — Registrant's telephone number

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing is for 'Other Events' and serves as a current report filed by Sonnet BioTherapeutics Holdings, Inc. on March 26, 2025.

When was Sonnet BioTherapeutics Holdings, Inc. incorporated?

The company was incorporated in Delaware.

What is the principal executive office address for Sonnet BioTherapeutics Holdings, Inc.?

The principal executive offices are located at 100 Overlook Center, Suite 102, Princeton, New Jersey, 08540.

Has Sonnet BioTherapeutics Holdings, Inc. operated under any previous names?

Yes, the company was formerly known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC.

What is the telephone number listed for Sonnet BioTherapeutics Holdings, Inc.?

The registrant's telephone number, including area code, is (609) 375-2227.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding Sonnet BioTherapeutics Holdings, Inc..

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.